☆ 4.6 Meeting Abstract

RANDOMIZED PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF NIVOLUMAB VS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: CHECKMATE 143

NEURO-ONCOLOGY (2017)

Journal

NEURO-ONCOLOGY

Volume 19, Issue -, Pages 21-21

Publisher

OXFORD UNIV PRESS INC

DOI: 10.1093/neuonc/nox036.071

Keywords

-

Categories

Oncology Clinical Neurology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.